Mesoblast Ltd (ASX:MSB)
Pharmaceuticals, Biotechnology & Life Sciences
Mesoblast Ltd (ASX:MSB) is a leader in providing allogeneic (off the shelf) cellular medicines. It owns a portfolio of late-stage product candidates with three product candidates in Phase 3 trials, being acute graft versus host disease, chronic heart failure and chronic low back pain due to degenerative disc disease. The company has facilities in Melbourne, New York, Singapore and Texas and is listed on the ASX and the NASDAQ.
Mesoblast Ltd (ASX:MSB) share price
Mesoblast Ltd (ASX:MSB) share price news
Today's ASX news
ASX 200 hits record high – WES, GXY & MSB shares in focus
The S&P/ASX 200 (INDEXASX:XJO) finished at an all-time high on Thursday. Wesfarmers (ASX:WES) shares are making headlines.
June 4, 2021
Healthcare ASX shares
Why the Mesoblast (ASX:MSB) share price is under the spotlight
The Mesoblast Limited (ASX:MSB) share price is under the spotlight after revealing its quarterly update to investors.
June 3, 2021
ASX Growth Shares
Mesoblast (ASX:MSB) share price is going through the roof – what’s happening?
The Mesoblast Limited (ASX: MSB) share price jumped as high as 12% today on results for the third quarter (Q3). What else is rocketing the Mesoblast share price upwards?
April 30, 2021
Today's ASX news
Why the Mesoblast (ASX:MSB) share price is under scrutiny
The Mesoblast Limited (ASX:MSB) share price is under scrutiny today after making an announcement about a strategic investor and the placement.
March 2, 2021
Editor's picks
Mesoblast (ASX:MSB) share price on watch for HY21, capital raising
The Mesoblast Limited (ASX:MSB) share price will be on watch this week with a capital raising and the release of the FY21 half-year result.
March 1, 2021
ASX Growth Shares
Here’s why the Mesoblast (ASX:MSB) share price is up 5%
The Mesoblast Limited (ASX:MSB) share price is up 5% after making a trial announcement.
February 11, 2021
Editor's picks
The Mesoblast (ASX:MSB) share price is going nuts
The Mesoblast Limited (ASX:MSB) share price is going nuts again today after giving an update.
January 11, 2021
Editor's picks
S&P/ASX 200 morning report – A2M, MSB & QBE shares in focus
The S&P/ASX 200 (INDEXASX:XJO) is set to open higher on Monday. A2 Milk Company (ASX:A2M) and Mesoblast (ASX:MSB) shares are in the news.
December 21, 2020
Editor's picks
Here’s why the Mesoblast (ASX:MSB) share price is plunging
The Mesoblast Limited (ASX:MSB) share price has plunged 43% after giving an update about its COVID-19 ARDS trial.
December 18, 2020